DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

ImmunoGen (NASDAQ: IMGN)

14.28 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $14.28 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.24
Previous Close $14.28
Daily Range $14.02 - $14.88
52-Week Range $5.34 - $19.43
Market Cap $1.2B
P/E Ratio -20.11
Dividend (Yield) $0.00 (0.0%)
Volume 1,342,012
Average Daily Volume 1,179,255
Current FY EPS -$1.42

Sector

Healthcare

Industry

Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary Rss Feed

Why Shares of ImmunoGen Inc Were Up Big Today

Shares of the cancer focused small-cap were up today on an otherwise down day for the markets.

Perilous Reversal Watch: Immunogen (IMGN)

ImmunoGen Inc: Finally Targeting Strong Returns?

This long-time sleepy stock has woken up recently on a flurry of good news. Does the future finally look bright for investors?

Why Cantor's Mara Goldstein Just Downgraded ImmunoGen

Benzinga's Top Downgrades

Analysts' Actions -- Bunge, Coach, Realogy and More

ImmunoGen: Back to a Development-Stage Biotech

With the biotech no longer collecting Kadcyla royalties, the pipeline becomes the focus of the release of quarterly earnings.

ImmunoGen's (IMGN) CEO Dan Junius on Q4 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q2 2015 Results - Earnings Call Webcast

ImmunoGen Is Climbing Higher... Again

ImmunoGen's shares continue to gain ground in the wake of early-stage trial results for its ovarian cancer drug.

See More IMGN News...

IMGN's Top Competitors

IMGN $14.28 (0.00%)
Current stock: IMGN
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB